Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

The performance of process measures in hepatitis C.

Kanwal F, Hoang T, Kramer J, Chrusciel T, El-Serag H, Dominitz JA, Asch SM.

Am J Gastroenterol. 2012 Oct;107(10):1512-21. doi: 10.1038/ajg.2012.201. Epub 2012 Jul 10.

PMID:
22777337
[PubMed - indexed for MEDLINE]
2.

Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.

Kramer JR, Hachem CY, Kanwal F, Mei M, El-Serag HB.

Hepatology. 2011 Jan;53(1):42-52. doi: 10.1002/hep.24024. Epub 2010 Dec 13.

PMID:
21254161
[PubMed - indexed for MEDLINE]
3.

Process of care for hepatitis C infection is linked to treatment outcome and virologic response.

Kanwal F, Hoang T, Chrusciel T, Kramer JR, El-Serag HB, Dominitz JA, Asch SM.

Clin Gastroenterol Hepatol. 2012 Nov;10(11):1270-1277.e3. doi: 10.1016/j.cgh.2012.07.015. Epub 2012 Jul 25.

PMID:
22841970
[PubMed - indexed for MEDLINE]
4.

Comparing clinical automated, medical record, and hybrid data sources for diabetes quality measures.

Kerr EA, Smith DM, Hogan MM, Krein SL, Pogach L, Hofer TP, Hayward RA.

Jt Comm J Qual Improv. 2002 Oct;28(10):555-65.

PMID:
12369158
[PubMed - indexed for MEDLINE]
5.

Quality of care in patients with chronic hepatitis C virus infection: a cohort study.

Kanwal F, Schnitzler MS, Bacon BR, Hoang T, Buchanan PM, Asch SM.

Ann Intern Med. 2010 Aug 17;153(4):231-9. doi: 10.7326/0003-4819-153-4-201008170-00005.

PMID:
20713791
[PubMed - indexed for MEDLINE]
6.

Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection.

Kanwal F, Hoang T, Chrusciel T, Kramer JR, El-Serag HB, Durfee J, Dominitz JA, Yano EM, Asch SM.

Dig Dis Sci. 2014 Feb;59(2):273-81. doi: 10.1007/s10620-013-2773-z. Epub 2013 Aug 10.

PMID:
23934366
[PubMed - indexed for MEDLINE]
7.
8.

Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy.

Rowan PJ, Al-Jurdi R, Tavakoli-Tabasi S, Kunik ME, Satrom SL, El-Serag HB.

J Clin Gastroenterol. 2005 Sep;39(8):731-6.

PMID:
16082286
[PubMed - indexed for MEDLINE]
9.

Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time?

Khokhar OS, Lewis JH.

Dig Dis Sci. 2007 May;52(5):1168-76. Epub 2007 Mar 15.

PMID:
17357838
[PubMed - indexed for MEDLINE]
10.

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Seeff LB, Hoofnagle JH.

Clin Liver Dis. 2003 Feb;7(1):261-87. Review.

PMID:
12691470
[PubMed - indexed for MEDLINE]
11.

Population-based hepatitis C surveillance and treatment in a national managed care organization.

Shatin D, Schech SD, Patel K, McHutchison JG.

Am J Manag Care. 2004 Apr;10(4):250-6.

PMID:
15124501
[PubMed - indexed for MEDLINE]
Free Article
12.

Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.

Antúnez I, Aponte N, Fernández-Carbia A, Rodríguez-Perez F, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):57-60.

PMID:
16929588
[PubMed - indexed for MEDLINE]
13.

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.

Castéra L, Hézode C, Roudot-Thoraval F, Lonjon I, Zafrani ES, Pawlotsky JM, Dhumeaux D.

Gut. 2004 Mar;53(3):420-4.

PMID:
14960527
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.

George MG, Tong X, McGruder H, Yoon P, Rosamond W, Winquist A, Hinchey J, Wall HK, Pandey DK; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2009 Nov 6;58(7):1-23.

PMID:
19893482
[PubMed - indexed for MEDLINE]
Free Article
15.

Treatment rates in patients with chronic hepatitis C after liver biopsy.

Narasimhan G, Sargios TN, Kalakuntla R, Homel P, Clain DJ, Theise ND, Bodenheimer HC Jr, Min AD.

J Viral Hepat. 2006 Nov;13(11):783-6.

PMID:
17052279
[PubMed - indexed for MEDLINE]
16.

The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs.

Kanwal F, Kramer JR, Buchanan P, Asch SM, Assioun Y, Bacon BR, Li J, El-Serag HB.

Gastroenterology. 2012 Jul;143(1):70-7. doi: 10.1053/j.gastro.2012.03.038. Epub 2012 Mar 28.

PMID:
22465432
[PubMed - indexed for MEDLINE]
17.

Treatment of chronic hepatitis C virus infection - Dutch national guidelines.

de Bruijne J, Buster EH, Gelderblom HC, Brouwer JT, de Knegt RJ, van Erpecum KJ, Schalm SW, Bakker CM, Zaaijer HL, Janssen HL, Reesink HW; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):311-22. Review. Erratum in: Neth J Med. 2008 Dec;66(11):456. Dosage error in article text.

PMID:
18663263
[PubMed - indexed for MEDLINE]
Free Article
18.

Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.

Hartwell D, Jones J, Baxter L, Shepherd J.

Health Technol Assess. 2011 Apr;15(17):i-xii, 1-210. doi: 10.3310/hta15170. Review.

PMID:
21473834
[PubMed - indexed for MEDLINE]
Free Article
19.

Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.

Rowan PJ, Tabasi S, Abdul-Latif M, Kunik ME, El-Serag HB.

J Clin Gastroenterol. 2004 Jul;38(6):530-4.

PMID:
15220690
[PubMed - indexed for MEDLINE]
20.

Limited success of HCV antiviral therapy in United States veterans.

Cawthorne CH, Rudat KR, Burton MS, Brown KE, Luxon BA, Janney CG, Fimmel CJ.

Am J Gastroenterol. 2002 Jan;97(1):149-55.

PMID:
11808940
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk